N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis
Gespeichert in:
| Veröffentlicht in: | Psychiatry and clinical neurosciences 2023-02, Vol.77 (2), p.119-121 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 121 |
|---|---|
| container_issue | 2 |
| container_start_page | 119 |
| container_title | Psychiatry and clinical neurosciences |
| container_volume | 77 |
| creator | Kishi, Taro Sakuma, Kenji Hatano, Masakazu Iwata, Nakao |
| description | |
| doi_str_mv | 10.1111/pcn.13502 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2732538797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2732538797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3072-108b1a6cef069d723feae125a7c05f7153fd30c6012d808377af0d3b39f9ee223</originalsourceid><addsrcrecordid>eNp1kEtOwzAQQC0EoqWw4AIoEhtYpLU9TZywqyp-EhQWsI5cZ6y6yg87oQorjsAZOQkpLSyQ8GYszdPT6BFyzOiQdW9UqWLIIKB8h_TZeEx9FrF4t_sDB58BC3vkwLklpRQgZPukByEAjaKwT-5nn-8fUmHdZqp1NZoCPV1az6mFeSurhcXCyAtv4rn1Npe1UZ7FV4MrTxapl2Mt14JCZq0z7pDsaZk5PNrOAXm-unya3vh3D9e308mdr4AK7jMazZkMFWoaxqngoFEi44EUigZasAB0ClSFlPE0ohEIITVNYQ6xjhE5hwE523grW7406OokN05hlskCy8YlXAAPIBKx6NDTP-iybGx375oSEPBxGAUddb6hlC2ds6iTyppc2jZhNFk3TrrGyXfjjj3ZGpt5jukv-RO1A0YbYGUybP83JY_T2Ub5BcdBhrE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2773524685</pqid></control><display><type>article</type><title>N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>Open Access Titles of Japan</source><creator>Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu ; Iwata, Nakao</creator><creatorcontrib>Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu ; Iwata, Nakao</creatorcontrib><identifier>ISSN: 1323-1316</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.13502</identifier><identifier>PMID: 36330886</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Acetylcysteine ; Acetylcysteine - pharmacology ; Acetylcysteine - therapeutic use ; Humans ; Mental disorders ; Meta-analysis ; Schizophrenia ; Schizophrenia - drug therapy ; Systematic review</subject><ispartof>Psychiatry and clinical neurosciences, 2023-02, Vol.77 (2), p.119-121</ispartof><rights>2022 The Authors. Psychiatry and Clinical Neurosciences © 2022 Japanese Society of Psychiatry and Neurology.</rights><rights>2023 Japanese Society of Psychiatry and Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3072-108b1a6cef069d723feae125a7c05f7153fd30c6012d808377af0d3b39f9ee223</citedby><cites>FETCH-LOGICAL-c3072-108b1a6cef069d723feae125a7c05f7153fd30c6012d808377af0d3b39f9ee223</cites><orcidid>0000-0001-7032-878X ; 0000-0002-9237-2236</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.13502$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.13502$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,1430,27911,27912,45561,45562,46396,46820</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36330886$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kishi, Taro</creatorcontrib><creatorcontrib>Sakuma, Kenji</creatorcontrib><creatorcontrib>Hatano, Masakazu</creatorcontrib><creatorcontrib>Iwata, Nakao</creatorcontrib><title>N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><subject>Acetylcysteine</subject><subject>Acetylcysteine - pharmacology</subject><subject>Acetylcysteine - therapeutic use</subject><subject>Humans</subject><subject>Mental disorders</subject><subject>Meta-analysis</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><subject>Systematic review</subject><issn>1323-1316</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtOwzAQQC0EoqWw4AIoEhtYpLU9TZywqyp-EhQWsI5cZ6y6yg87oQorjsAZOQkpLSyQ8GYszdPT6BFyzOiQdW9UqWLIIKB8h_TZeEx9FrF4t_sDB58BC3vkwLklpRQgZPukByEAjaKwT-5nn-8fUmHdZqp1NZoCPV1az6mFeSurhcXCyAtv4rn1Npe1UZ7FV4MrTxapl2Mt14JCZq0z7pDsaZk5PNrOAXm-unya3vh3D9e308mdr4AK7jMazZkMFWoaxqngoFEi44EUigZasAB0ClSFlPE0ohEIITVNYQ6xjhE5hwE523grW7406OokN05hlskCy8YlXAAPIBKx6NDTP-iybGx375oSEPBxGAUddb6hlC2ds6iTyppc2jZhNFk3TrrGyXfjjj3ZGpt5jukv-RO1A0YbYGUybP83JY_T2Ub5BcdBhrE</recordid><startdate>202302</startdate><enddate>202302</enddate><creator>Kishi, Taro</creator><creator>Sakuma, Kenji</creator><creator>Hatano, Masakazu</creator><creator>Iwata, Nakao</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7032-878X</orcidid><orcidid>https://orcid.org/0000-0002-9237-2236</orcidid></search><sort><creationdate>202302</creationdate><title>N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis</title><author>Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu ; Iwata, Nakao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3072-108b1a6cef069d723feae125a7c05f7153fd30c6012d808377af0d3b39f9ee223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acetylcysteine</topic><topic>Acetylcysteine - pharmacology</topic><topic>Acetylcysteine - therapeutic use</topic><topic>Humans</topic><topic>Mental disorders</topic><topic>Meta-analysis</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kishi, Taro</creatorcontrib><creatorcontrib>Sakuma, Kenji</creatorcontrib><creatorcontrib>Hatano, Masakazu</creatorcontrib><creatorcontrib>Iwata, Nakao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kishi, Taro</au><au>Sakuma, Kenji</au><au>Hatano, Masakazu</au><au>Iwata, Nakao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2023-02</date><risdate>2023</risdate><volume>77</volume><issue>2</issue><spage>119</spage><epage>121</epage><pages>119-121</pages><issn>1323-1316</issn><eissn>1440-1819</eissn><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>36330886</pmid><doi>10.1111/pcn.13502</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7032-878X</orcidid><orcidid>https://orcid.org/0000-0002-9237-2236</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1323-1316 |
| ispartof | Psychiatry and clinical neurosciences, 2023-02, Vol.77 (2), p.119-121 |
| issn | 1323-1316 1440-1819 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2732538797 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; Open Access Titles of Japan |
| subjects | Acetylcysteine Acetylcysteine - pharmacology Acetylcysteine - therapeutic use Humans Mental disorders Meta-analysis Schizophrenia Schizophrenia - drug therapy Systematic review |
| title | N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A52%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N%E2%80%90acetylcysteine%20for%20schizophrenia:%20A%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Kishi,%20Taro&rft.date=2023-02&rft.volume=77&rft.issue=2&rft.spage=119&rft.epage=121&rft.pages=119-121&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.13502&rft_dat=%3Cproquest_cross%3E2732538797%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2773524685&rft_id=info:pmid/36330886&rfr_iscdi=true |